NASDAQ
Heron Therapeutics, Inc. (HRTX) has a free cash flow growth of 78.97% as of Friday, May 29, 2026. This represents a 146.89% increase compared to its 12-month average of -168.41%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.